Skip to content

Compensation of the Management Board

The Compensation Report of Fresenius Medical Care AG for the fiscal year 2023 (Fiscal Year) was prepared in accordance with the requirements of Section 162 of the German Stock Corporation Act (Aktiengesetz – AktG).

The Compensation Report includes individualized and comprehensive information on the compensation within the meaning of Section 162 paragraph 1 AktG awarded and due to current and former members of the management board and of the supervisory board in the Fiscal Year and benefits within the meaning of Section 162 paragraph 2 AktG awarded or promised to members of the management board.

Invitation of the Annual General Meeting 2020 incl. agenda
Voting result for item 6 of the agenda of the Annual General Meeting 2020

The Compensation System 2020+ makes a significant contribution of promoting the business strategy and the long-term, sustainable development of Fresenius Medical Care. It provides effective incentives for the achievement of the strategic goals as well as for the long-term value-creation of the Company, taking into account the interests of patients, shareholders, employees and other stakeholders.

The Compensation System 2020+ is based on the following guiding principles:

Compensation system 2020+

The Compensation Report summarizes the main elements of the system for the compensation of the members of the Management Board. The amounts and structure of the Management Board compensation for the past fiscal year are also explained therein.

Compensation Report 2023
Compensation Report 2022
Compensation Report 2021
Related content

Our Management Board currently consists of several members. The international composition and the varied responsibilities reflect our global operations.

Fresenius Medical Care is committed to responsible management that is focused on achieving a sustainable increase in the value of the Company.